Acceleware Ltd. announced a comprehensive loss of $1.9 million for 2025, down from a $2.0 million income in 2024, reflecting reduced revenue and R&D spending as it winds down its RF XL Marwayne Pilot. The company is progressing with its next-generation RF XL 2.0 technology for heavy oil production, planning a $5-6 million pilot in Saskatchewan with conditional government support. Acceleware also advances projects in mineral processing and amine regeneration, aiming to commercialize its radio frequency heating solutions across multiple industrial sectors. The company is restructuring convertible debt to secure financing and expects to demonstrate commercial viability through pilot deployments in 2026.
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
PNC Financial Services Group reported Q2 2026 adjusted EPS of $4.85 and record revenue of $6.88 billion, surpassing analyst expectations. The growth was driven by a 15.5% rise in net interest income and a 31.4% increase in fee income, reflecting stro...
Greenlight, a leading cannabis operator, expanded its Ohio presence by opening four new dispensaries and adding in-state manufacturing, reaching the state's maximum allowed eight dispensaries. This move strengthens Greenlight's position in Ohio's lim...
Halper Sadeh LLC is investigating whether shareholders of Element Solutions Inc (ESI), Crinetics Pharmaceuticals (CRNX), and Solstice Advanced Materials (SOLS) are receiving fair treatment in their respective sale and merger transactions. The firm hi...
